IRMD
IRMD
US46266A1097
iRadimed Corporation
Loading chart...

Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Latest News

Related stocks

PRCT
PRCT • United States
PROCEPT BioRobotics Corporation
18.4 USD
1.05B USD 1Y -48.5%
LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
CBLL
CBLL • United States
CeriBell, Inc.
23.63 USD
906.87M USD 1Y +89.1%
CNMD
CNMD • United States
CONMED Corporation
44.42 USD
1.33B USD 1Y -3%
QDEL
QDEL • United States
QuidelOrtho Corporation
13.42 USD
920.28M USD 1Y -55.5%
ALMR
ALMR • United States
Alamar Biosciences, Inc.
25.27 USD
1.75B USD
VREX
VREX • United States
Varex Imaging Corporation
18.46 USD
783.88M USD 1Y +56.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
42.4% p.a.
Max Drawdown (5Y)
-49.4%
Sharpe Ratio (5Y)
0.40
Beta Factor
0.91
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 48.9 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (42.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.7% in the extended horizon.
ende